Drug Cost Implications Highlight SPT Week in Review

Top news of the week from Specialty Pharmacy Times.

Switch to Extended Half-Life Hemophilia Factor Products Found to Double Costs

Pharmacy benefit manager study indicates that moving patients with hemophilia from standard half-life to extended half-life coagulation factor products carries a significant cost increase.

Click to read more...

Drug Costs Responsible for Nearly Entire Price Tag of Hereditary Angioedema Care

Pharmacy benefit manager reports specialty drugs drive 97% of spending for hereditary angioedema care.

Click to read more...

Specialty Drug Spending Grows While Traditional Medicine Spending Drops

Spending on specialty medications is rapidly approaching half of overall medicine spending from a small volume of prescriptions filled.

Click to read more...

Specialty Drugs Power Growth in Pharmacy Benefit Spend

New treatments for cystic fibrosis, migraines, and multiple sclerosis expected to help push specialty drug costs on the pharmacy benefit to nearly 50% of total drug spending by 2020.

Click to read more...

Adherence Lacking to High-Cost Multiple Sclerosis Disease-Modifying Drugs

Study finds improving adherence to disease-modifying multiple sclerosis medications could reduce clinical relapses while saving on medical costs.

Click to read more...